Biomedical subjects
Publications and source records attributed to Andréas Bikfalvi.
Malignant glioma are especially difficult to model in vivo. Here we review the most recent strategies for designing relevant models of glioma. These should greatly contribute to identification of new tumor regulating molecules and facilitate testing of inhibitors to be used in therapeutical trials as well as the drug resistance that they might confer.
Fibroblast growth factors such as FGF-2 are potent mitogens for endothelial cells and induce their assembly into vascular-like structures in culture and in in vivo assays. However, their putative functions during physiological vascularization are poorly documented. In this study, the eye was used as a model for analyzing the vascular defects caused by targeted FGF inhibition in transgenic mice. Choroidal and retinal vascularizations were studied by immunohistochemistry on whole-mount preparations. Soon after activation of the transgene, angiogenesis that normally occurs during the second half of gestation in the choroid was strongly inhibited resulting in poor capillary density and branching. Later retinas strikingly failed to develop a primary vascular plexus suggesting a defect in induction of vessel assembly. Hyaloid vessels that supply the retina during the fetal period did not regress at birth and later gave rise to unexpected massive neovascularization. This model illustrates major functions of FGFs at different early stages of physiological vascularization. Both the failure in hyaloid regression and the intense angiogenic invasion of endothelial cells into the retina may serve as a model for some related human ocular pathologies.
Recent advances in the understanding of the molecular control of angiogenesis have shown that this process is essential for tumor development and spread. The identification of a great many of ligands, receptors or intracellular signalling molecules have allowed to unravel some of the regulatory loops involved. Especially noteworthy is the fact that developmental regulators seem now to play a role in tumor angiogenesis. Furthermore, these studies have allowed to identify novel therapeutic targets and to develop novel molecules and strategies for cancer therapy. This indicates that tumor angiogenesis is at present a major focus of cancer research.